These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The biotechnology revolution and its regulatory evolution. Hoffman DE Drake Law Rev; 1988-1989; 38(3):471-550. PubMed ID: 16086466 [No Abstract] [Full Text] [Related]
3. The new RAC: restructuring of the National Institutes of Health recombinant DNA Advisory Committee. Beach JE Food Drug Law J; 1999; 54(1):49-53. PubMed ID: 11758560 [No Abstract] [Full Text] [Related]
4. Biotechnology: can a new technology survive? Withers WW; Kenworthy PG St Louis Univ Law J; 1987; 31(3):673-97. PubMed ID: 11650845 [No Abstract] [Full Text] [Related]
5. Clear-cut biotechnology regulations are a must. Jefferson EG Med Mark Media; 1985 Jul; 20(7):28-9, 32-3. PubMed ID: 10272849 [No Abstract] [Full Text] [Related]
6. The challenge of biotechnology. Gore A; Owens S Yale Law Policy Rev; 1985; 3(2):336-57. PubMed ID: 11652468 [No Abstract] [Full Text] [Related]
7. Review of NIHRAC focuses on gene therapy. Fox JL Biotechnology (N Y); 1995 May; 13(5):431-2. PubMed ID: 9634783 [No Abstract] [Full Text] [Related]
10. Corporate responsibility for recombinant DNA activities. Berger BA Univ Toledo Law Rev; 1981; 12(4):913-24. PubMed ID: 11649592 [No Abstract] [Full Text] [Related]
11. NIH launches discussion of in utero gene therapy...and seeks to repair 'flaw' in review process. Wadman M Nature; 1998 Oct; 395(6701):420. PubMed ID: 9774086 [No Abstract] [Full Text] [Related]
12. The National Institutes of Health system for enhancing the science, safety, and ethics of recombinant DNA research. Shipp AC; Patterson AP Comp Med; 2003 Apr; 53(2):159-64. PubMed ID: 12784849 [TBL] [Abstract][Full Text] [Related]
13. US election: Agencies of change. Tollefson J Nature; 2008 Sep; 455(7212):451-2. PubMed ID: 18818625 [No Abstract] [Full Text] [Related]
14. Plan to end genetics panel troubles EPA. Science; 1996 Aug; 273(5278):1035. PubMed ID: 11644823 [No Abstract] [Full Text] [Related]
15. Regulation of genetic engineering: less concern about Frankensteins but time for action on commercial production. Karny GM Univ Toledo Law Rev; 1981; 12(4):815-68. PubMed ID: 11649588 [No Abstract] [Full Text] [Related]
16. Biotechnology on the RAC--FDA/NIH regulation of human gene therapy. Rainsbury JM Food Drug Law J; 2000; 55(4):575-600. PubMed ID: 12025851 [No Abstract] [Full Text] [Related]
17. Special informed consent requirements are included in protocol review procedures. Maloney DM Hum Res Rep; 1995 Jul; 10(7):1-2. PubMed ID: 11654274 [No Abstract] [Full Text] [Related]
20. 2003 budget. War effort shapes U.S. budget, with some program casualties. Malakoff D Science; 2002 Feb; 295(5557):952-4. PubMed ID: 11834796 [No Abstract] [Full Text] [Related] [Next] [New Search]